HPV Vaccine: Cost-effective Way to Prevent Anal Cancer

Published: November 2, 2010

Nov. 2, 2010 –The human papillomarvirus (HPV) shot is a cost-effective way to prevent genital warts and anal cancer in men who have sex with men. This is the finding of a new study that appears in The Lancet.

In 2010, there will be about 5,260 new cases of anal cancer diagnosed in the U.S, and about 720 people will die from this disease, according to the American Cancer Society. There are no routine prevention programs or screening tests for anal cancer.

HPV vaccines protect against certain types of HPV that are linked to cervical cancer and anal cancer. A sexually transmitted disease, HPV or genital warts can be transmitted through vaginal, anal, and oral sex. Nearly 80% of cases of anal cancer are linked to two of the types of HPV that the vaccine targets.

Full text of article available at link below –

Leave a Reply